Laurel Habel to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications Laurel Habel has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
0.131
-
Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast Cancer Res Treat. 2011 Sep; 129(2):549-56.
Score: 0.090
-
Cardiovascular Outcomes in Relation to Antihypertensive Medication Use in Women with and Without Cancer: Results from the Women's Health Initiative. Oncologist. 2020 08; 25(8):712-721.
Score: 0.042